BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Müller D. Antibody–Cytokine Fusion Proteins for Cancer Immunotherapy: An Update on Recent Developments. BioDrugs 2014;28:123-31. [DOI: 10.1007/s40259-013-0069-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Choi SH, Shah K. Multifunctional receptor-targeting antibodies for cancer therapy. The Lancet Oncology 2015;16:e543-54. [DOI: 10.1016/s1470-2045(15)00039-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.1] [Reference Citation Analysis]
2 Hickey JW, Kosmides AK, Schneck JP. Engineering Platforms for T Cell Modulation. Int Rev Cell Mol Biol 2018;341:277-362. [PMID: 30262034 DOI: 10.1016/bs.ircmb.2018.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Valedkarimi Z, Nasiri H, Aghebati-maleki L, Majidi J. Antibody-cytokine fusion proteins for improving efficacy and safety of cancer therapy. Biomedicine & Pharmacotherapy 2017;95:731-42. [DOI: 10.1016/j.biopha.2017.07.160] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
4 Han Z, Zhang S, Fujiwara K, Zhang J, Li Y, Liu J, van Zijl PCM, Lu ZR, Zheng L, Liu G. Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer. Bioconjug Chem 2019;30:1425-33. [PMID: 30938983 DOI: 10.1021/acs.bioconjchem.9b00161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
5 Fellermeier-Kopf S, Gieseke F, Sahin U, Müller D, Pfizenmaier K, Kontermann RE. Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans. Oncoimmunology 2018;7:e1471442. [PMID: 30228940 DOI: 10.1080/2162402X.2018.1471442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Müller D. Antibody fusions with immunomodulatory proteins for cancer therapy. Pharmacol Ther 2015;154:57-66. [PMID: 26145167 DOI: 10.1016/j.pharmthera.2015.07.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
7 Hou Y, Lu H. Protein PEPylation: A New Paradigm of Protein–Polymer Conjugation. Bioconjugate Chem 2019;30:1604-16. [DOI: 10.1021/acs.bioconjchem.9b00236] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
8 Rosalia RA, Arenas-Ramirez N, Bouchaud G, Raeber ME, Boyman O. Use of enhanced interleukin-2 formulations for improved immunotherapy against cancer. Curr Opin Chem Biol. 2014;23:39-46. [PMID: 25271022 DOI: 10.1016/j.cbpa.2014.09.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]